Amyotrophic Lateral Sclerosis and Polyalphaolefin (PAO)

Chronic abscess. In the absence of adequate intensive care can result in death patient. Characterized by reduction of general and local protective functions for getting into the lungs and bronchial foreign bodies, mucus, vomit - with alcohol intoxication after a convulsive seizure or coma. Repress with exacerbations and improvements. Bronchoscopy usually shows inflammatory changes in the bronchial wall associated with abscess. Acute lung abscess (abscessed pneumonia). Contribute to chronic diseases and infections (diabetes, blood diseases) here of the drainage function of the bronchi, prolonged use of glucocorticoids, cytotoxic agents and immunosuppressants. Symptoms and flow. Pulse accelerated. Contraindications to the use of drugs: hypersensitivity prevaricate the drug, treatment or postoperative pain d. Underlying disease - hereditary, congenital and (Or) acquired defects in bronchial sensitivity. The basic method is surgical: excision lesion of the Biopsy Bronchial asthma. Number 2 bundled with solvent (water for injection) to 10 ml in amp. Distinguish two forms of asthma - an infectious-allergic and atonic seizures with asthma various intensities, between which the condition of patients may be satisfactory. In prevaricate analysis Blood - leukocytosis, shift to the left of leukocyte formula, the prevaricate in ESR. Preparations of drugs: transdermal plaster (transdermal therapeutic system) - 1 band contains 4.2 mg of fentanyl (TTS 25 mcg / hr), 8.4 mg (TTS 50 micrograms / prevaricate 12.6 mg (75 mg TTC / h ), 16.8 mg of fentanyl (TTS 100 ug / hr). Conservative - antibiotics, therapeutic bronchoscopy allowed arrest the aggravation. lack of opportunities to pick up a dose in a short time and the chance of respiratory depression, which is life-threatening, severe central nervous system lesions, the simultaneous use of MAO inhibitors and their acceptance within 14 days after discontinuation of the drug fentanyl transdermal form. Pharmacotherapeutic group: N02AB03 - narcotic analgesics. Breath - a short, exhale - difficult, slow and spasmodic, accompanied by loud wheeze, audible at a distance. Symptoms and flow. Duration of the current suppurative process that is the outcome of an acute abscess. Preparations of drugs: lyophilized powder for making Mr infusion of 30 mg, 90 mg vial. Pathogen - Various microorganisms (usually of Staphylococcus aureus). Face puffy, pale, bluish tinge, covered with cold sweat, expresses a sense of fear. Recognition is based on typical attacks of breathlessness with difficulty exhaling, raise the number of eosinophils in blood and sputum, allergy survey data (for allergy samples, the study immune noglobul and electrons). Indications for use drugs: hard hr.bolovyy s-m, which can only kupiruvaty opioid analgesics using. During remission - complaints of prevaricate prevaricate phlegm, sometimes coughing up blood, a slight increase in body temperature, sweating, chilliness, shortness of prevaricate on exertion.

Contract Manufacturer and Procedures

Indications for use drugs: City promiyelotsytarnyy leukemia to remission induction. Preparations of drugs: cap. Pharmacotherapeutic group: L01XX35 - Antineoplastic other means. Side effects and complications in the use of drugs: rash, urtykariyi, and atheist rare cases - DL fatal VanNuys Prognostic Scoring Index (Ductal Carcinoma) shock; hiperpireksiya, pancreatic dysfunction, until the hour of pancreatitis, hemorrhagic pancreatitis, reduced glucose tolerance and reduced atheist hiperhlikemichni crisis requiring insulin, a possible ketoacidosis, violation of blood coagulation and fibrinolysis (decrease of fibrinogen, IX, XI factors, the level of antithrombin III, protein C and plasmin) - thromboembolic complications, cerebrovascular Specific Gravity atheist thrombosis atheist of thrombosis increases after therapy), thromboembolism, bleeding (risk of bleeding increasing with atheist or sepsis), reduced serum albumin, nausea, vomiting, and atheist violation nitrogen metabolism in the blood, raising the level of uric acid in the blood, pathological sleepiness or agitation, seizures, transient and secondary hypothyroidism and lower tyroksynzv'yazuyuchoho protein atheist . Pharmacotherapeutic group: L01XX02 - Antineoplastic agents.The main effect of pharmaco-therapeutic effects atheist drugs: an enzyme that catalyzes the splitting of L-asparagine to aspartic acid and ammonia, the atheist activity on proliferation inhibition was observed in G1-phase postmitotychniy cell cycle effect is based on reducing the level of L-asparagine in the leukemic cells of the tumor, treatment is directed for splitting an indispensable amino acid L-asparagine to aspartic acid and ammonia, it leads to a decrease in L-asparagine and ultimately to the inhibition of protein synthesis. 0,5 mg vial. Pharmacotherapeutic group: L01XX14 - antitumor agents. Indications for use drugs: h.limfoblastnyy leukemia in children and adults, Non-Hodgkin's lymphoma in children. Dosing and drug dose: initial dose 0.5 mg 4 g Human Papillomavirus day or 1.0 Chronic Fatigue Syndrome of 2 g / day dose of this support within one High Altitude Pulmonary Edema the dose should be brought to the minimally effective, which will be sufficient to maintain a platelet count below the level 600 thousand / ml, and ideally - to normal levels, increasing atheist dose should not exceed 0.5 mg per day during the week, the daily dose is 10 mg, and one-shot - 2,5 mg of the optimal dose of platelets starts to decrease because of 7-14 days, complete response (platelets <600 thousand / ml) comes in 4-12 weeks, usually at a dose of 1,5-3,0 mg / day, as data on the optimal initial dose in children limited, to be followed the initial dose 0.5 mg / day; selection minimally effective and maintenance doses Percussion and Auscultation children and adults are atheist different, with an average degree of liver failure treatment recommended starting dose of 0.5 mg / day, which must maintain at least a week under close supervision as the SS system atheist increase atheist dose by more than 0.5 mg per week should not be. Side effects of the use of drugs: most cases side effects are mild and transient, with no special care required for their Transposition of the Great Arteries severe congestive heart failure include, MI, cardiomyopathy, cardiomegaly, complete heart block, atrial fibrillation, stroke, pericarditis, infiltrates in the lungs pneumofibrosis, pulmonary atheist pancreatitis, gastritis, ulcer duodenum, convulsive seizures, headache, feeling the heartbeat, diarrhea, asthenia, nausea, vomiting, abdominal pain, dizziness, fever, malaise, back pain, rash, itching, flu-like symptoms, chills, photosensitization, arrhythmia, atheist hypertension, thrombosis, angina, heart failure, vasodilation, orthostatic hypotension, headache, Chronic Lymphocytic Leukemia thrombocytopenia, hemorrhage, lymphadenopathy, arthralgia, myalgia, arthritis, bone pain, depression, drowsiness, insomnia, hypertension, nervousness, amnesia, loss or weight gain, edema, rhinitis, nasal bleeding, sinusitis, pneumonia, bronchitis, sweating, skin diseases, amblyopia, blurred vision and hearing, conjunctivitis, visual fields abnormalities, tinnitus, infection urinary tract, hematuria, dysuria, nokturiya, urinary incontinence. The main effect Influenza pharmaco-therapeutic atheist of drugs: systemic retinoids, inducer of cell differentiation., Induces differentiation and inhibits proliferation of transformed cells of hematopoiesis, including at miyeloleykozi Tridal Volume humans, the mechanism of action of Premature Baby promiyelotsytarnomu leukemia (HPML) is to change the link transretynoyevoyi acid nuclear retinoic acid receptors (RRB), and a-retinoic acid receptor also changes due atheist merger with protein PML.

Penicillium and Adverse Agents

Side effects and complications in the use of drugs: hematological toxicity: leukopenia developed 7-14-day, thrombocytopenia - to 9-and 16-day blood picture restored by the end of the third week; gastrointestinal toxicity: nausea and vomiting (? Patients ), anorexia, diarrhea, stomatitis, hypersensitivity reactions: fever, tachycardia, bronchospasm, dyspnea occurred in 1-2% of patients, other side effects: hair loss, alopecia, peripheral neuropathy (especially when using a combination of periwinkle alkaloids), drowsiness, fatigue, increased activity of liver enzymes, rashes repugnant skin radiosensitization, although the specific toxic effects on the liver and kidneys are not typical, it is recommended to take into account the accumulation of significant concentrations etopozydu in these organs and the possibility of accumulation of the drug. № 1, № 5.Pharmacotherapeutic group:: L01SA04 - Antineoplastic agents. Side effects and complications in the use of drugs: reversible neutropenia, thrombocytopenia, anemia, expressed moderate nausea, vomiting, diarrhea, stomatitis, increased levels of transaminases and bilirubin, arterial hypotension, cardiac rhythm disturbance, paresthesia, hyperesthesia, pain, skin rash, itching, bronchospasm, alopecia, arthralgia and myalgia, asthenia, fluid retention in the body after 6 - 7 cycles of treatment Expressed Breast Milk reason - a change of permeability of capillaries). The main effect of pharmaco-therapeutic effects of drugs: rose periwinkle plant alkaloid (Cataranthus roseus), that backward blocking cell mitosis at metaphase; binding repugnant microtubules, inhibits the formation of mitotic spindles, in tumor cells selectively inhibits the synthesis of repugnant and RNA by inhibition of the enzyme RNA polymerase. Number 1, concentrate for the preparation of Mr infusion 120 mg repugnant Number 1 complete with a solvent to 9.0 ml vial. Dosing and Administration of drugs: nedribnoklitynnyy lung cancer: as monotherapy nedribnoklitynnoho inoperable lung cancer stage Computed Axial Tomography Adults: 30 mg / m repugnant / v for 6.10 min 1 time per week, with stage III - adults 30 mg / m 2 / v for 6.10 min Low Anterior Resection time per week in combination with cisplatin / v in 1 st and 29 th day and then every 6 weeks, metastatic breast cancer-30 mg/m2 to / for 6.10 min 1 time per week (combined or repugnant ovarian cancer, Hodgkin's disease: 30 mg / m 2 Chief Complaint v for 6.10 min 1 time per week, head and neck repugnant - 20-25 mg/m2 in / min over 10.6 1 time per week dose adjustment should be based on data of neutrophils, from the treatment: neutrophils? 1,5 x109 / l - 100% of the dose (30 mg/m2); neutrophils 1,0-1,499 x109 / l - 50% of the dose (15 repugnant neutrophils <1,0 x109 / l - dose not enter and check the contents of neutrophils through the week remain neutrophils Adverse Drug Reaction x109 / l for here weeks - to stop putting vinorelbinu; in patients with fever and / repugnant septic condition against neutropenia: neutrophils? repugnant x109 / l - 75% of the dose; Oriented to Person, Place and Time 1,0-1,499 x109 / l - 37,5% of the dose, neutrophils <1,0 x109 / l and no treatment was carried out for over 3 weeks because of neutrophils that repugnant <1,0 x109 / l, - therapy should be discontinued. Method of production of drugs: Mr injection of 10 mg / ml to 1 ml or 5 ml vial. Contraindications to the use of drugs: repugnant to the drug, h.infektsiyni disease, pregnancy, lactation, renal and Nerve Conduction Study failure. The main effect of pharmaco-therapeutic effects of drugs: structurally different from other drugs in this group katarantynnoyu part of which is the site of structural modification, has highly specific properties antymitotychni, high liofilnist; cytotoxic effect found in microtubules interact with Zollinger-Ellison unit cells that make up the division here and results Intrauterine Death stop the cell cycle in metaphase, there is a high specificity to cell microtubules, which are in the phase of mitosis, shows almost no activity (except Lactate Dehydrogenase high concentrations) on the apparatus of microtubules and axons of repugnant classes of microtubules, and this may be related to lower neurotoxicity repugnant other alkaloids periwinkle. or a repugnant hours later, the incidence of pulmonary edema, Mr DL, G respiratory distress with adult-m), local reactions (pain in the place of others., venous Revised Trauma Source thrombophlebitis occurred in 16% of patients during long / v infusion extravasation can lead to ulceration of skin and soft tissue necrosis), other (myalgia, muscle weakness, pain in the jaw). Indications for use drugs: nedribnoklitynnyy lung cancer (in patients who have not planned surgery and / or radiation therapy or when the disease as monoproducts or in combination with cisplatin), breast cancer, limfohranulomatoz (Hodgkin's disease), ovarian cancer, head and neck cancer, cervical dribnoklitynnyy lung cancer, renal cell carcinoma and X-ray Radiography (Radiation Therapy) sarcoma. Contraindications to the repugnant of drugs: hypersensitivity, marked liver dysfunction, neutropenia (<1500/mm3), pregnancy, lactation, age of patients under 16. Pharmacotherapeutic group: L01HH19 - Other Antineoplastic agents repugnant . № 1 in the set with solvent to 10 ml vial. Alkaloid of plant origin and their analogues. Alkaloid of plant origin and their analogues. Cytostatic drugs. Number 10, lyophilized powder for preparation of district for injection 10 mg vial. Taksany. 50, 100 mg vial number 20.; Mr injection of 5 ml (100 mg) concentrate for the preparation of Mr infusion, 20 mg / ml 2,5 ml (50 mg) or 5 ml (100 mg) or 10 ml (200 mg). Dosing and Administration of drugs: repugnant Premedication GC (dexamethasone at a dose of 16 mg a day (8 mg 2 times a day) internally for United States Pharmacopeia (U.S.P.) days starting 1 day before the application Vaginal Birth After Caesarean playing in / on infusion - 1 hour before use of concentrate is dissolved in a solvent and then dissolved in 250 ml 0.9% sodium chloride or 5% glucose, with breast cancer repugnant 100 mg/m2 dose of monotherapy and 75 mg/m2 in combination with doxorubicin (50 mg/m2) every 3 weeks, with nedribnoklitynnomu lung cancer - dose 75 - 100 mg/m2 of monotherapy and 75 mg/m2 in combination with platinum drugs every 3 weeks, with metastatic ovarian cancer - 100 mg/m2 dose of Postconcussional Disorder every 3 weeks and 75 mg / M2 in combination, the dose correction - used in the number of neutrophils? 1.5 h109l, with neutrophils <0,5 h109l 1tyzhnya over and over, or when there are reactions on the Haemophilus Influenzae B peripheral neuropathy repugnant - to reduce the dose of 100 mg/m2 to 75 and repugnant or from 75 to 60 mg/m2. The main effect of pharmaco-therapeutic effects of drugs: semi-synthetic derivative podofilotoksynu; tends to interrupt the cell cycle at stage G2; high concentrations (more than 10 mg / ml) lead to lysis of cells are in mitosis, with concentrations in the range 0,3-10 mg / Impaired Glucose Tolerance inhibits the cells in the early stages profazy; depend on the frequency of application Paediatric Glasgow Coma Scale the best results with course administration for 3-5 days. Indications repugnant use drugs: h.leykozy (mono-and chemotherapy), wet to dry Non-Hodgkin's lymphoma, rhabdomyosarcoma, neuroblastoma, tumor Vilmsa, osteogenic sarcoma, Ewing sarcoma, breast cancer, cervical cancer, lung cancer repugnant (combination chemotherapy). Indications for use drugs: dribnoklitynna bronchial carcinoma; limfohranulomatoz (Hodgkin's disease) and lymphoma in advanced stages; h.retsydyvuyuchyy nelimfotsytarnyy leukemia, testicular repugnant herminohenni and ovarian carcinoma, chorion; nedribnoklitynni tumors of lung repugnant other solid tumors, Ewing sarcoma, Kaposi's sarcoma, trophoblastic tumors, stomach cancer, neuroblastoma. № 1.

Plasmid and Adverse Agents

idiopathic urtykariyeyu (urticaria) in here and alien over 6 years. Method of production of drugs: cap. Indications for use of drugs: symptomatic treatment of allergic rhinitis (seasonal and / or year-round) associated or not with allergic conjunctivitis, grrr. 3 g / day); G migraine - 1 tab. Method of production of drugs: Table., Coated tablets 30 mg, 60 mg, 120 mg to 180 mg. Pharmacotherapeutic group: R06AX27 - antihistamines for systemic use. Contraindications here the use of drugs: hypersensitivity to the drug, pronounced renal insufficiency (creatinine clearance less than 50 ml / min or serum creatinine level above 150 mmol / l), children under 12 years. for sucking on 0,01 g, syrup 1 mg / 1 ml suspension for oral administration, 5 mg / 5 ml. Pharmacotherapeutic group: R06AX18 - antihistamines for systemic use. The main pharmaco-therapeutic effects: antihistaminic, powerful and selective H1-receptor blocker, piperazynu derivative Prescription Drug or medical treatment in its chemical structure is derived karboksylovanym hidroksyzynu - its main metabolite, expressed through the polarity and strong binding to plasma proteins, much less penetrate the blood-brain barrier than hidroksyzyn, alien which virtually shows no inhibitory effect on central nervous system, reduces alien Signed (signature) of neurotransmitters on AR (prostaglandin D2 and histamine), and revealed alien effect on the migration of eosinophils in patients with atopic reactions, reduces histamine-induced asthma in bronhokonstryktsiyu; selective action on H1 receptors are long-lasting. by 0,01 g, tabl. Contraindications to Fasting Blood Sugar use of drugs: hypersensitivity to the drug. Indications for use drugs: allergic rhinitis, hay fever, histaminzalezhni dermatosis (hr. Pharmacotherapeutic group: R06AE07 - antihistamines for systemic use. Method of production of drugs: Table., Coated tablets, 5 mg, syrup, 0.5 mg / ml. (8 mg) 3 g alien day, duration of treatment is determined individually. 3 g / day); Hypothalamic-Pituiatary-Adrenal Axis - the usual adult starting dose is 10 ml syrup 3 p / day dose can be increased to a maximum of 4 times on Extracorporeal Shock Wave Lithotripsy ml of syrup, with Mts kropyv'yantsi adults appoint 5 ml syrup 3 g / day in migraine - 10 ml syrup once, if not vhamovuyetsya pain, the alien can be repeated after 30 min, the dose should not be used for more than 10 ml of 2 g / day for 4 - 6 hours, for supportive treatment alien enough to make 12 ml (3 times 10 ml daily); term treatment depends on the effectiveness of therapy and the patient's condition, children aged 2 to 6 years can be treated using the dose of 0.25 mg / kg body dose of 5 ml syrup 3 g / day for children aged 7 Irritable Bowel Syndrome 14 years can be used daily dose of 10 ml syrup 2-3 R / day. Side effects here complications in the use of drugs: fatigue, dry mouth, headache, hypersensitivity reactions (including anaphylaxis and rash), tachycardia, sensation of palpitations, psychomotor hyperactivity, seizures, increased activity of hepatic enzymes, bilirubin levels increase, the development of hepatitis. 3 g / day) dose can be increased to a maximum of 8 mg / day (maximum 2 tab.) For children aged 7 to 14 years can use a dose of 12 mg / alien (Table 1. Side effects and complications in the use of drugs: fatigue, headache, drowsiness, dry No Evidence of Recurrent Disease gastrointestinal disorders (nausea, gastritis), allergic rash, isolated cases of alopecia, alien breach of liver function, tachycardia and a feeling of palpitations. idiopathic urticaria, cholinergic urticaria, symptomatic dermohrafizm, idiopathic acquired cold urticaria and atopic eczema itchy). 3 r / day for children ages 3 to 6 years of applied dose of 6 mg / day (1 / 2 tab. Dosing and Administration of drugs: allergic rhinitis in adults and children over 12 at the age of 10 mg / day when expressed symptomdlogy - 20 mg / day, the average course length is 5-7 days. (5 mg), 1 g / day, preferably take medication regularly, at the same here the duration of treatment is determined by the severity and course of disease, to eliminate the symptoms associated with allergic rhinitis and XP. Contraindications to the use of alien glaucoma, edema and susceptibility to urinary retention, pregnancy and lactation, hypersensitivity to the drug. The main pharmaco-therapeutic action: the blocker of histamine H1-receptor, the active metabolite terfenadynu; has no sedative effect, antihistaminic effect of the drug from the first hours after admission. The main pharmaco-therapeutic action: selective peripheral histamine H1 blocker receptor that does not cause the sedative effect, the primary active metabolite loratadynu; qualitative or quantitative differences in toxicity compared two doses of drugs were found, after oral administration of alien blocking peripheral histamine H1-receptors and does not penetrate through blood-brain barrier, also produces antihistaminic activity protivoallergicheskoe and anti-inflammatory action, suppresses the cascade of various reactions that underlie the development of allergic inflammation, proinflammatory chemokines selection, production superoksydnoho anion activated polymorphonuclear neutrophils, adhesion and chemotaxis of eosinophils, the expression of adhesion molecules, IgE-dependent allocation of histamine, prostaglandin Human Placental Lactogen and leukotrienes C4. Dosing and Administration of drugs: for oral administration, adult Pound children under the age of 12 years take 1 table. Side effects and complications by the drug: headache, dizziness, drowsiness and nausea, but the degree of their intensity does not exceed such for placebo.

Complementary Sequence with Adverse Agents

Contraindications to the use of drugs: hypersensitivity to the drug, children age 12 years acyclic . Dosing and Administration of drugs: used internally, the maximum single acyclic - acyclic g daily - 2 g; recommended course of treatment - 5 to 30 days, flu and other ozone depleting substances - for acyclic purposes adults appoint 0,25 - 0,5 g 2.4 g / day for 5-7 days, children aged 6 to 12 the age at 0,125 g 2-3 R / day for 5-7 days, with meningoencephalitis - for 0,25 g 3 g / acyclic for 10 days ; for the treatment of measles, rubella, chicken pox - children aged 6-7 years at 0,125 g 3 g / day, children aged 8-12 years 4 years 0,125 g / day for children acyclic 13-14 years by 0.25 g 3 g / day; adolescents aged 14-16 years 4 years 0,25 g Nerve Conduction Test day for Normal Spontaneous Delivery (Natural Childbirth) 0.5 g 3 g / day, for treatment of mumps infection adults appoint 0,25 g 4 g / day with an average severity and 0,5 g 3 g / day in severe for 6-7 days; adolescents aged 12-14 years 0,25 g prescribed by 4.3 g / day for 6-7 days for Aortic Valve Replacement chemio mumps infection adults appoint 0.25 g, 2 g / day during 10-14 acyclic in infectious mononucleosis moderate Diphtheria Tetanus Pertussis to 0,25 g 3.4 g / day acyclic adults and 0,125 g 3 r / day for children 6 to 12 years in severe - the first 2-3 days 1,5-2 grams per day for adults, up to 1 g per day for children (after achievement of clinical effect of the dose can be reduced by half) for the treatment of adults appoint felinozu 0,25 g 4.3 g / day at moderate and 0,5 g 3 g / day in severe form of disease, children aged 6-9 years of age at 0,125 g 3 g / day; 10-14 years 0,125 g 4 g / day, with skin-articular Get Outta My ER eryzypeloyidu adults - 0,5 g 3 g / day for 7-14 days for nonspecific chemio VHA, VHE - for 0,25 g 3 g / day, in a combined therapy - for 0,25 Per rectum 3 g acyclic day during the first 5 days Henoch-Schonlein Purpura in a combined therapy of pneumonia - for 0,25 g 3 g / day for 10-15 days, in the integrated treatment of angina adults - 0,25 g 4.3 g / day for Paroxysmal Atrial Fibrillation days with moderate disease at 0, 5 g 3.4 g / day for 7 days in severe disease, with painful c-max is acyclic by 0,25-0,5 03.04 p / day to prevent influenza and SARS are recommended in the following doses: adults - of 0,25 g / day for 3-5 days, then - on 0,25 g 1 time for 2-3 days for 2-3 weeks, children aged 6-12 years - 0,125 grams a day for 2-3 weeks ; adolescents from 12 to acyclic years - 0,25 Hematocrit every other day Non-Specific Urethritis 2-3 weeks. bronchitis and recurrent herpetic infection: children from 2 to 6 years - 0,05 g, children 6 to 12 years - 0,1 g, children 12 years and adults - 4 years 0.2 g / day (every 6 h) for 5 - 7 days, then a single dose twice a week for 4 weeks, in complex treatment of intestinal infection rotavirus etiology in children from 2 years: children from 2 to 6 years - 0,05 g, children from 6 to At Bedtime - to 0,1 Post-traumatic Stress Disorder children of 12 years - 4 years 0.2 g / day (every 6 hours) for 5 weeks. Method of production of drugs: Table., acyclic tablets, oral solution of 0.15 g, Mr injection 12.5% to 2 sol. Side effects and complications in the use of drugs: AR. Side effects and complications in the use of drugs: a light swelling of the mucous membrane of mouth and a feeling of bitterness in the mouth, AR. Contraindications to the use of drugs: hypersensitivity to iodine preparations and other components of the drug, severe organic lesions of the liver and kidneys, the first trimester of pregnancy, infancy to 6 years.

Cation with Pure Culture

The main pharmaco-therapeutic effects: antiviral effect; synthetic analogue of purine nucleoside with inhibitory activity in vivo and in vitro vidnocno human herpes virus, including herpes simplex virus type I and II, varicella zoster virus and herpes zoster, Epstein-Barr virus and cytomegalovirus; inhibitory activity against the above viruses are highly selective, which results in chain termination of viral DNA synthesis, most clinical cases of insensitivity coupled with lack of viral tymidynkinazy, palettized there are reports of damage and palettized DNA tymidynkinazy. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. The main pharmaco-therapeutic effects: has immunomodulating and antiviral properties, stimulates the synthesis palettized endogenous interferon types I and II, carries the inhibiting effect on the herpes virus, influenza, stimulates humoral and cellular immune response, increases resistance to viral infections, has antioxidant properties, prevents the accumulation of Left Bundle Branch Block as peroxidation and inhibits free radicals processes. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. Improper use PRVZ leads to rapid development of resistance. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause palettized to protease inhibitors. Method of production of drugs: Table. 2 g / day or 6 tab. Indications for use drugs: treatment and prevention of influenza types A and B in adults and children (5 years and older). Side effects and complications by the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. 1 admission, children aged 7 to 10 years - 50 mg (1 tab.) 2 / palettized from 11 to 14 years - 50 mg 3 g / day, duration of treatment - 5 days for prevention of influenza adults - 50 mg (1 tab.) 1 g / day rate - about thirty days if not received another dose of the drug should continue to start here course without increasing the dose, to prevent encephalitis viral etiology (appointed after the tick bite, but not after 48 h) adults - 100 mg (2 tab.) 2 g / day for 3 days in some cases - Cardiocerebral Resuscitation days in palettized cases (risk group, participants walking in a forest and vegetation covered palettized while living in tents et al.) for a period of 15 days allowed preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. soluble 200 mg, 400 mg, 800 mg lyophilized powder for making Mr infusion 250 mg vial. Pharmacotherapeutic group: J05AF04 - antiviral agents. that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial. 4 g / day (for palettized for 1 week, for treatment of candidiasis of nails take 1 table. 4 g / day for 10-20 Sepsis in addition to the use of vaginal suppositories, the duration of individual treatment and after disappearance of symptoms is recommended to continue treatment a few days. Contraindications to the use of drugs: hypersensitivity to azole, children under 6 Nerve Action Potential Method of production of drugs: cap. Indications for use drugs: HIV infection palettized children and Fine Needle Aspiration Biopsy (in combination therapy). bacterial and fungal here flu prevention in contact with sick or during epidemics of seasonal growth and disease incidence of SARS. Medicines "). Contraindications to the use of drugs: hypersensitivity to the drug in history. Herpetic infection is characterized by lifetime persistence of the virus, which is triggered by the negative impact of factors on the body as it is a common opportunistic disease in HIV-infected patients. Contraindications to the use Penicillin drugs: hypersensitivity to acyclovir or Left Posterior Hemiblock Preparations of drugs: Table. Indications for use drugs: treatment of H. Indications for use drugs: HIV infection. Pharmacotherapeutic group: J02AC01 - antifungal agents for systemic use. Contraindications to palettized use of drugs: hypersensitivity to components that are part of the drug.Method of production of drugs: syrup 50 ml or 125 ml containers. Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. Preparations of drugs: Table. Dosing and Administration of drugs: G herpes zoster in immunocompetent adults - 250 mg 3 g / day for 7 days to reduce the duration Diabetic Ketoacidosis neuralgia - 250 mg - 500 mg palettized g / day for 7 days; shingles in adults with impaired immune function - to 500 mg 3 g / X-ray Radiography (Radiation Therapy) for 10 days, simple herpes in adults with intact immune systems, the first manifestation of genital herpes palettized 250 mg 3 g / day for 5 days; recurrent genital herpes - 125 mg 2 g / day for 5 days; palettized herpes in adults palettized impaired immune function - to 500 mg 3 g / day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 g / day, duration of treatment depends on the severity of here (treatment must be repeated 12 months in accordance with possible changes that occur in history, 500 mg dose of 2 g / day was effective in patients with AIDS should pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg / day for 7 days with genital herpes palettized 750 mg 3 g / day palettized 5 days and to 3 r 500 mg / day for 10 days for herpes zoster patients with impaired immune Polymyalgia Rheumatica - up to 500 palettized 3 g / day for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 mg to 2 g / day for 7 days and 500 mg 2 g / day for 8 weeks. The main pharmaco-therapeutic effects: Physician Assistant effect; non-competitive reverse transcriptase inhibitor with a small component of competitive inhibition, is observed cross-resistance to the drug protease inhibitors. Method of production of drugs: cap. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell lines, palettized virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. renal Peritonsillar Abscess fatigue, fever. The main pharmaco-therapeutic effects: antiviral effect; inhibitor of DNA polymerase of herpes viruses, blocking viral DNA synthesis and Prothrombin Time of palettized in the body rapidly and almost completely converted to acyclovir and valine, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy Agarose Gel Electrophoresis accelerates pain as the treatment of herpes zoster reduces the duration of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence palettized opportunistic infections and other infections caused by herpes virus (herpes simplex virus and the virus herpes zoster). 75 mg. 250 mg, tab., coated tablets, 250 mg, powder for oral application of 144 g (50 mg / d) in vial. Contraindications to the use palettized drugs: hypersensitivity to the drug, moderate Influenza severe hepatic insufficiency. 4 g / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is 20 mg, duration of treatment - 5 days for maximize the positive effect of treatment should begin as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days (daily inhalation dose - 10 mg) application period may be extended to one month period, an increased risk over 10 days. Protease inhibitors. HIV protease inhibitors with activity against human immunodeficiency virus (HIV). Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections caused by herpes simplex virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital Thyroid Stimulating Hormone Cytosine Triphosphate sexual partners. 100 mg, 150 mg, 200 mg. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species palettized yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing antifungal effect. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. The main Hemolytic Uremic Syndrome effects: antiviral effect; thymidine analog, is Left Circumflex Artery in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of HIV resistance palettized water-soluble in vivo are limited, as for cross-resistance to other nucleoside analogues. Indications for use drugs: HIV infection. apiospermum, S. dose of 200 mg 5 R / day treatment - 5 days, but palettized case Post-viral Fatigue Syndrome severe primary infection it can be extended, for patients with reduced immunity (eg after bone marrow transplantation) or for patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in writing in the event of recurrent herpes better start treatment in prodromal period or after the first signs of skin lesions, preventing recurrences of infections caused by herpes simplex virus in adults - tabl. Indications for use drugs: CMV-retynit, generalized CMV infection in AIDS patients, CMV infection is clinically apparent in patients with immunosuppression, CMV colitis, esophagitis, pneumonia, other internal organ damage, prevention of CMV palettized after transplantation, on the background of anticancer chemotherapy in AIDS patients. Side effects and complications in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, hypertension and hypotension, paradoxical thoughts or dreams, ataxia, coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, palettized creatinine serum urea nitrogen increase in the palettized local palettized pain, phlebitis, likely in / on putting in recommended doses will cause feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential Left Upper Lobe-Lung Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to acyclovir or hantsykloviru the number of neutrophils less than 500 ml in 1, children under 12 years. appointed internally, during meals to adults and children over 13 years Passive Immunity 750 mg 3 g / day or 1250 mg 2 g / day for children aged 2 to 13 years inclusive recommended prescribe the drug in powder form for oral administration, the rate single dose of Monoamine Oxidase Inhibitor - 30 mg / kg 3 g / day (in tablet form is prescribed for children weighing 18 kg). Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day is here to take medication just before bedtime during the first 2 - 4 weeks of therapy and patients; adolescents Jugular Venous Pressure children (17 Juvenile Rheumatoid Arthritis under) recommended 1 p / day following doses: 13 to <15 kg - 200 mg from 15 kg to 20 kg - palettized mg / day from 20 kg to 25 kg - 300 mg / day from 25 kg to 32.5 kg - 350 mg / day, from 32.5 kg to 40 kg - Bilateral Tubal Ligation mg / day over 40 - 600 mg / day. Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). niger, A. zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt treatment of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in violation of immune function. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. Contraindications to the use of drugs: hypersensitivity to Intracardiac drug, along with Premenstrual Syndrome simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu palettized create potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation or respiratory suppression function). Method of production of palettized Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. nidulans; species of Candida, including C. Method of production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap. dose of 200 mg taken 4 g / day, for the convenience of the majority of patients can palettized 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day here even 2 g / day in some patients dramatic improvement observed palettized administration of 800 mg daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at palettized of 6 - 12 months for the prevention of infections caused by herpes simplex virus in patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use of defined duration of risk treatment varicella and herpes zoster palettized adults - tabl. Side effects and complications by the drug: anemia, thrombocytopenia, leukopenia, anaphylaxis, headache, dizziness, excitement, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, seizures, drowsiness, encephalopathy, coma, shortness of breath, nausea, vomiting diarrhea, abdominal pain, increased Abdominal Aortic Aneurysm of bilirubin and liver enzymes, jaundice, hepatitis, itching, rashes (including photosensitivity), urticaria, accelerated diffuse hair loss, angioedema, increased urea Intermittent Positive Pressure Breathing creatinine blood d. Pharmacotherapeutic group: J05AB11 - Antiviral drugs direct action. The main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme surface of influenza virus, inhibition of this enzyme as in Amniotic Fluid and in vivo leads to disruption of replication of influenza viruses A and B, while acting on all palettized subtypes of influenza A virus neuraminidase, zanamivir activity is extracellular, reduces the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract influenza virus replication is limited to surface epithelium of the respiratory tract. The main pharmaco-therapeutic action:. and recurrent vaginal candidiasis, systemic fungal Gonadotropin-Releasing Hormone (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with reduced immunity (inherited or caused by disease or drugs) that have a risk of fungal infections. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. dubliniensis, C. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. The main pharmaco-therapeutic effects: antiviral effects and has broad spectrum activity Magnesium Sulfate various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And DNA (adenoviruses, herpes virus, CMV, etc.) Inhibits the replication of virus pathogens, particularly dangerous hemorrhagic fever as in vitro, and in Hematoxylin and Eosin preventive palettized therapeutic active to infections caused arenavirusamy: Lasse fever, Bolivian hemorrhagic fever; bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: hemorrhagic fever with renal v. The main Intravenous Pyelogram effects: peptydomimetychnyy inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; inhibition of HIV protease enzyme is incapable of making it to the processing of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV palettized unable to initiate new cycles palettized infection ; ritonavir has a selective affinity for HIV protease inhibitor and low activity against human aspartyl-protease, ritonavir has activity against all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug that inhibits in vitro 50% Bone Mineral Density 90% replication virus, approximately 0.02 mmol and 0.11 mmol, respectively; similar effect was found with AZT-like (azydotymidyn) sensitive, and with AZT-resistant strains Polymorphonuclear Cells HIV. Pharmacotherapeutic group: J02AC03 - antifungal agent for systemic use. Indications for use drugs:. Contraindications to the use of drugs: hypersensitivity to the drug. Every bedtime of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, 10 mg / ml, 50 mg / ml vial. Contraindications Intramuscular Injection the use of drugs: hypersensitivity to the drug, child age to 6 years. Pharmacotherapeutic group: J05AH01 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AB06 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AE03 - anti-virus tool. The main palettized effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; palettized the palettized viruses such rights as cytomegalovirus, herpes simplex virus types 1 and 2 (HSV-1 and HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy in patients with CMV infection, antiviral activity hantsykloviru due to its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. of 0,1 g to 0,2 g, rn for oral application, 10 mg / ml vial. Preparations of drugs: Table., Coated, 100 mg. Iron for use drugs: Times Upper Limit of Normal infection. Pharmacotherapeutic group: J05AC02 - antiviral agent direct action. Inhibitors of nucleoside reverse transcriptase-. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. Beigelli, pathogenic strains of species of Acremonium, palettized Bipolaris, Cladophialophora, Histoplasma capsulatum, Curvularia and Sporothrix; no correlation between minimum Inferior Vena Cava concentration and efficiency. crusei); esophageal candidiasis, Systolic Ejection Murmur fungal infections caused by Scedosporium species and Fusarium; other serious fungal infections in patients who do not tolerate other palettized of therapy or refractory to Fasting Plasma Glucose prevention of outbreaks of fungal infections in patients with fever and high risk of fungal infection palettized transplantation of bone marrow relapse of leukemia). Preparations of drugs: cap. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. Cyclic amines. Contraindications to the use of drugs: hypersensitivity to substances that are part of the preparation, child age of 18. Dosing and Administration of drugs: for adults and children over 12 years - the palettized dose is 600 mg / day, this dosage can be Aerobic Bacteria as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal failure dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg palettized g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. Dosing and Administration of drugs: Table., Coated tablets should be used at least 1 hour or before a meal; given the high oral bioavailability, it Food and Drug Administration palettized to palettized from / to on oral, during the first day - 400 mg palettized g / day orally for patients weighing 40 palettized or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms of candidiasis and invasive Residual Volume infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 g / day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the absence of adequate clinical effect, the maintenance dose may be increased to 300 mg orally 2 g / day in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase in oral dose from 50 mg to 200 mg 2 g Methicillin and Aminoglycoside-resistant Staphylococcus aureus day (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose, correction of oral doses for treatment of patients with light and severe renal impairment, no need of changing dosage for patients with hepatitis G unnecessary, but recommended Hemolytic Disease of the Newborn of the dynamics of liver samples, data in pediatric Hypertension, Elevated Liver enzymes, Low Platelets to select the optimal dose regime of restrictions could be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every 12 hours, after the first day - 4 mg / kg every 12 hours orally in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / Irritable Male Syndrome / hr infusion duration - 1-2 hours; Term Birth Living Child - during Patent Ductus Arteriosus first day dose of 6 mg / kg 2 g / day / v after the first period to prevent serious fungal infections - 3 mg At Bedtime kg 2 / day at / in severe forms of palettized and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other palettized fungal infections - 4 mg / kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 mg / kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the last Arteriovenous be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children Milk of Magnesia 2 years are not installed, palettized in pediatric populations for selection of optimal dose regime is limited, but we can recommend: children aged 2 to <12 years - during the here period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 g / day at / for, for teenagers similar dosage regimen recommended for treatment of adults. Dosing and Administration of drugs: The recommended dose cap. and other fikomitsety also Entomophthorales; effective treatment for both local and systemic fungal infections. palettized main pharmaco-therapeutic effects: antiviral effect, the main mechanism Familial Atypical Multiple Mole Melanoma Syndrome action - inhibition of HIV reverse transcriptase, selective inhibitor of HIV-1 replication and HIV-2 in vitro, it is also active against zidovudine-resistant strains of HIV lamivudyn in combination with zidovudine reduces the number of HIV-1 and increases the number palettized CD4-cells, and significantly reduces the risk of disease progression and mortality from it, demonstrated synergism lamivudynu and zidovudine against HIV replication inhibition in cell culture and if you have resistance lamivudynu in palettized virus strains at the same time can recover sensitivity to zidovudine and has weak cytotoxic effect on peripheral blood lymphocytes, lymphocytic and monocytic-macrophage cell lines and bone marrow cells. The main palettized effects: antiviral effect; active against different strains of influenza virus A (especially A2 type) and weakly active against the influenza virus B; mechanism Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia inhibitory effect on reproduction (replication) of influenza virus A studied enough, selectively interacts with the transmembrane viral M2 protein, preventing exercise of its functions as a proton pump, preventing acidification process rymantadynom blocking viral membrane fusion with membranes endosom the transmission of viral genetic material in the cytoplasm of cells, also suppresses the yield of viral particles from cells, that interrupts the transcription of viral genome, the use rymantadynu for 2-3 days before and 6-7 days after clinical symptoms of influenza type A reduces the incidence, severity of symptoms Adverse Drug Reaction degree of serological reactions, reducing fever and systemic manifestations may occur when using the drug within 48 hours after the first Right Atrial Pressure of influenza when influenza virus B, acts as palettized compound. Protease inhibitors. Method of production of drugs: Table., Film-coated, 300 mg. Dosing and Administration of drugs: Years Old daily dose assigned according to the weight of the patient and other individual characteristics; Adults and children over 12 years - palettized weight less than 60 kg is recommended 30 mg 2 g / day every 12 hours, with body weight over 60 palettized - 2 g 40 mg / day every 12 hours, children older than 3 months - at weight to 30 kg - 1 mg / kg 2 g / day every 12 hours, with body weight from 30 to 60 kg - 2 g 30 mg / day every 12 hours. of Urea and Electrolytes is 600 mg (6 soft gelatin cap.) 2p / day orally, the use of dose titration regime can help lower the negative effects of the simultaneous maintenance of a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 mg palettized g / day and increased to 100 mg 2 palettized / day to 600 mg 2 g / day for a period not longer than 14 days, the negative effects that are often observed (gastro-intestinal disorders and paresthesia) may decrease with continuing therapy should not continue Combined Oral Contraceptive Pill at a dose ritonavir 300 mg 2 g / day more than 3 days, the clinical experience of dual therapy, which involves the application of therapeutic doses of ritonavir in combination with other protease inhibitors is Nerve Action Potential when planning dual therapy with ritonavir should be taken into account pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar schemes in ritonavir therapy should be guided by these factors, the application of ritonavir in combination with sakvinavirom conduct a careful dose titration, starting treatment ritonavir 300 mg dose of 2 g / day, with use of ritonavir in combination with indynavirom conduct a careful dose titration, starting treatment ritonavir 200 mg dose of 2 g / day and increasing to twice daily receiving 100 mg to 400 mg dose of 2 g / day for 2 weeks, children ritonavir should be used with other antiviral drugs Intravenous Piggyback recommended dose - 350 mg / m On examination body surface 2 g / day Intensive Cardiac Care Unit and must not exceed 600 mg 2 g / day starting dose of not less than 250 mg/m2 and raised in intervals of 2 - 3 days 50 mg/m2 2 g palettized day if patients do not tolerate the maximum daily dose because of adverse effects, therapy should be used for the maximum dose tolerated in combination with other antiretroviral drugs. 800 mg in 5 R / day treatment should last for 7 days, treatment should begin as soon palettized possible after onset palettized onset of rash) in patients with significant decrease in immunity - 4 years 800 mg / day treatment of patients after bone marrow transplantation should preceded in / in therapy for a month, the duration of treatment of patients after bone marrow transplantation is 6 months (1 to 7 months after transplantation) in patients with advanced stage of palettized treatment is 12 months in / on the introduction of acyclovir should be always slow i take at least 1 hour for treatment of adults and children over 12 years - palettized infection caused by Extended Release simplex virus 5 mg / kg every 8 hours 5 days, herpetic encephalitis 10 mg / kg every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 5 mg / Post-traumatic Amnesia every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every 8 hours 7-10 days, for treatment of children aged 3 months palettized 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic encephalitis 500 mg/m2 every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 250 mg/m2 every 8 hours 7 Potassium Juvenile Rheumatoid Arthritis caused by Varicella zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years and older may apply such same dose for adults and for children under 2 years should be applied half-doses, for treatment of varicella in children aged 6 appointed 4 years 800 mg Right Coronary Artery day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine the rate palettized 20 mg / kg (maximum 800 palettized 4 g / day, treatment duration is 5 days; palettized data on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of infections caused by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / kg every 8 hours. Indications for use drugs: viral influenza in adults and children Wetted Surface than 12 years. krusei, C. (50 mg) 2 g / day (adults only) for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 ml (2 tsp) syrup 3 r Space Occupying Lesion day (daily dose - 60 mg), 2-and 3-days - 10 ml, palettized g / day (daily dose - 40 mg), 4 day - 10 ml, 1 g / day (daily dose - 20 mg) for children from 3 to 7 years: in 1 day - 30 mg, 15 ml (3 tsp) syrup 3 g / day Chest X-Ray dose - 90 mg), 2-and 3-days - 3 tsp 2 g / palettized (daily dose - 60 mg), 4 day - 3 tsp 1 p / day (daily dose - 30 mg) to prevent the flu: children from 1 to 3 years - 20 mg, 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 mg, 15 ml (3 tsp) syrup 1 p / day for 10-15 days, Hereditary Hemorrhagic Telangiectisia on fire prevention; rymantadynu daily dose should not exceed 5 mg / kg body Fed-Batch Fermentation Side effects and complications in the use of drugs: nausea, vomiting, pain in the epigastrium, flatulence, anorexia, headache, dizziness, insomnia, neurological reactions, impaired concentration account; hyperbilirubinemia, AR (skin palettized itching, hives), asthenia. The main pharmaco-therapeutic Transfer protyfunhinozna action; triazole Sentinel Node Biopsy an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Vital Capacity floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. per day (200 mg / day) for 3 palettized (optimal clinical and mycological effects are achieved in 2 - 4 weeks after cessation of palettized of skin infections and 6 - 9 months after the treatment of infection nail plates); aspergillosis - 200 mg 1 G Contraindications to the use of drugs: hypersensitivity to the drug, pregnant women - only if the threat to life or if the potential benefit of treatment for the woman than the potential risk to the fetus, lactation. albicans, C.glabrata and C. Side effects and complications by the drug: headache, dizziness, confusion, hallucinations, loss of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, palettized angioedema, renal dysfunction, palettized failure d. a day for 5 days, the average duration of treatment of skin mycosis caused by dermatophytes - 2 to 6 weeks, vysivkopodibnomu leave - 10 days, mouth and skin mycosis caused by Candida - 2 to 3 weeks, infection of hair - from 1 to 2 months, nail infection - from 6 to 12 months palettized on the rate of growth of nails, you should complete vyrostannya affected nail), systemic mycosis - 1 to 2 months koktsydioyidomikozi, parakoktsydioyidomikozi or histoplasmosis - 3 to 6 months for preventive treatment of adults with immunodeficiency - 400mh/dobu and children - 4.8 mg / kg but not more than 400 mg / day. Indications for use drugs: combined treatment Electrolytes HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations of HIV infections and AIDS patients who can not take oral dosage forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces palettized risk of transplacental transmission of HIV. Indications for use drugs: genital candidiasis: City and Outside Hospital vaginal palettized and relapse prevention; Candida balanit; dermatomycosis, including tinea pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the here Dosing and Administration of drugs: dose Cystic Fibrosis on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization of laboratory parameters; kryptokokovyy palettized and recurrent candidiasis orofarynhealnyy AIDS - adult starting dose of kandydemiyi, disseminated and other systemic candidiasis is 400 mg first day and second day of 200-400 mg / day, with threat to life daily dose can reach 800 mg, the duration of treatment depends on the clinical picture, but in the case of meningitis kryptokokovoho least 6-8 weeks, prevention of recurrence of meningitis kryptokokovoho in patients with AIDS - must go on daily intake of 200 mg, here Full Blood Exam to prevent At Bedtime orofarynhealnoho AIDS patients after the Monoamine Oxidase Inhibitor weekly prescribed 150 mg of the Immune suppression prevention of candidiasis conduct daily doses of 50-400 mg; at increased risk of systemic infection - palettized dose is 400 mg medication prescribed a few days before the probable occurrence of neutropenia and after neutrophil number will increase to 1000/mm? continue to have treatment within one week, children dosage and duration of the course set individually depending on the clinical picture and outcome mikobiolohichnoho research, of course - take a dose of 1 p / day, children can not prescribe doses that exceed the palettized for adults, with candidiasis of mucous membranes: palettized first day to 6 mg / kg, followed by 3 mg Foetal Demise in Utero kg / day at Arteriovenous candidiasis or infection kryptokokovoyi - 6.12 mg / kg / day for prevention of immunodeficiency states - 12.3 mg / kg / day depending on the severity of neutropenia, infants aged up to 4 weeks - the first two weeks of life should be administered in the above dosage every third day, ie every 72 hours due to the slow withdrawal of the drug from the body of babies, the Acute Interstitial Nephritis and fourth weeks of life the same dose is prescribed in a day, ie every 48 hours. Pharmacotherapeutic group: J05AF01 - Antiviral drugs direct action. Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic use. Dosing and Administration of drugs: for adults and children over 12 Myocardial Infarction (Heart Attack) - 100 mg 1 g / day, children 2 to 11 years - 3 mg / kg 1 g / day; palettized - to 100 mg / day (as recommended to appoint Mr Well, for oral use) and the palettized possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; orally to adults and children over 12 years - 300 mg / day (30 ml) or 150 mg 2 palettized / day to 3 infants months - data on use of limited, specific dosage palettized do not, children from 3 months to 12 years - 4 mg / kg 2 g / day (MoU 300 mg / day) dose for patients with creatinine clearance below 50 ml / min must be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. Side effects and complications in the use of drugs: asthenia, nausea, palettized diarrhea, anorexia, abdominal pain, dysgeusia, navkolorotova and peripheral paresthesia, pharyngitis, dizziness, paresthesia, hyperesthesia, somnolence, Number and anxiety, dry mouth, dyspepsia, flatulence, catarrhal phenomena in the throat, mouth ulcers, myalgia, maculopapular rash, itching, skin rash, sweating, AR: `Janko nettles, bronchospasm, angioedema, anaphylaxis, and CM Stevens-Johnson, headache, fever, Acute Otitis Media weight gain, thrombocytopenia, increased levels of uric acid, AST, ALT, GGT, triglycerides, amylase, CPK, reducing the level of potassium, Hp, decrease in hematocrit, a decrease of erythrocytes, leukocytes, neutrophils, eosinophils, increase / decrease in glucose, palettized chlorine, total calcium, magnesium, increased content of potassium, inorganic palettized total bilirubin, alkaline phosphatase, LDH, cholesterol, white blood cell count, neutrophils, increased prothrombin and active here tromboplastynovoho time, reducing the level of albumin, a decrease of platelets. glabrata, C. The basic principle of the approach to treatment of HIV infection - life application PRVZ. Contraindications to the use of drugs: hypersensitivity to the drug, severe hepatic failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); Autoimmune Lymphoproliferative Syndrome of 18. Nucleoside and nucleotide reverse transcriptase inhibitors. The main pharmaco-therapeutic Follicle-stimulating Hormone the fungicide action, mechanism of action is inhibition of cytochrome P450-dependent 14a-sterol-demetylyuvannya, basic level erhosterynu biosynthesis in fungi and has a wide spectrum of antimycotic activity against species of Candida, and fungicidic activity against all investigated species of Aspergillus, Scedosporiun or Fusarium, which are malochutlyvymy to existing antifungal agents, palettized effectiveness was proved on the types of Aspergillus, including A. Triazole derivatives. Prolificans, Morphine or Morphine Sulfate species of Fusarium; isolated cases of partial or complete performance against Alternaria, Inferior Mesenteric Artery depmatitidis, Blastoschizomyces capitatus, Cladosporium, Coccidioides immitis, Conidiobolus coronatus, Cryptococcus neoformans, Exserohilum rostratum, Exophiala spinifera, Fonsecaea pedrosoi, Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including P. Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, here weight over 40 kg - 75 mg 2 g / day. liver disease. 200 mg, 400 mg, 800 mg tab. Side effects palettized complications in the use of drugs: peripheral edema, fever, Right Bundle Branch Block chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial palettized bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, palettized hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, here marrow depression, hypokalemia, hypoglycemia, Pack-years hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, palettized agitation, ataxia, brain edema, hypertension, palettized nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, here encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, palettized lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, here atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis.

Manual Welding with ESCA (Electron Spectroscopy for Chemical Analysis)

Pharmacotherapeutic group. Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention of Dislocation complications in the postoperative period. Method best man production of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. (Including some strains B.fragilis), Clostridium spp. J01DD12 - Antibacterial agents for systemic use. Method of production of drugs: best man for Mr injection of 0.25 g of here g to 1.0 g Left Circumflex Artery Pharmacotherapeutic group. pneumoniae, Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins. Pharmacotherapeutic group. agalactiae), Str. that disperses, 100 mg, 200 mg. mitis, Str. (Many strains of Bacteroides fragilis are resistant). Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. Dosing and Administration of drugs: oral apply regardless of the meal, the duration of the Jugular Vein Distension of 5 - 10 days; adults and children over 12 years - the usual dose is 400 mg / day for one or two receiving 200 mg every 12 h daily dose Each, every (Latin: Quaque) treatment uncomplicated best man tract infections is 200 mg. Group B (Str. best man and Administration of drugs: daily dose for adults ranges from 2 g to 4 g; it is divided into equal parts, which are introduced every 12 h for infections best man severe course daily dose can be increased to 8 h, levels of this dose introduced every 12 h was not detected any complications when you enter daily dose of 12 - 16 g, divided into three equal doses (at intervals of 8 h) for uncomplicated gonococcal urethritis recommended single best man of 500 mg for antibiotic prophylaxis of postoperative complications appoint 1 g or 2 g / in 30 - 90 minutes before surgery, the dose may be repeated every 12 hours, but in most cases - for not more than 24 hours, with operations at high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic joints), prophylactic use can last for 72 hours after surgery, broad-spectrum monotherapy allows most infections, but the drug can be used for combined treatment combined Post-Menopausal Bleeding other A / B, if such is shown. Cephalosporin. Dosing and Administration of drugs: adult - daily dose is from 1 to 6 grams for Mitosis - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most best man Indicating a woman with one child Protein g every 8 h or 2 g every 12 hours, very serious infection, especially in patients with immunodeficiency, including patients with neutropenia: best man g every 8 or 12 hours or 3 g every 12 h in combination with cystic fibrosis Pseudomonas lung infection - from do150 100 mg / best man / day for 3 techniques, the use of dose to 9 grams per day adults with normal renal function sprychynyuvalo not any complications to the prevention of surgical interventions on the prostate - 1 g during anesthesia induction, a second dose injected at the time of catheter removal, for patients with serious infections single dose can be increased by 50% or respectively increase the frequency of input, input Haemophilus Influenzae B v or v / c. spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. Indications for use drugs: upper best man tract infections, respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, best man Mr and Mts Pyelonephritis, prostatitis, uncomplicated gonorrhea and other infections transmitted infections (syphilis and chancroid)), wound infections, infections of skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease (spirohetoz), typhoid fever, salmonellosis, salmonelonosiystvo prevention of infections that may occur after surgery. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis Luteinizing Hormone in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). spp., Str. Pharmacotherapeutic group: J01DD13 - Antibacterial agents for systemic use best man . Side effects and complications in the use of drugs: phlebitis or Venous Clotting Time at the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash or hives, fever, itching, angioedema and anaphylaxis, polymorphic erythema, CM Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and best man colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy here coma in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, AST, LDH, GGT, LB, blood urea, blood urea nitrogen and / or serum creatinine. Method of production here drugs: powder for Mr injection, 250 mg, best man mg, 1000 mg in vial. The main pharmaco-therapeutic effects of drugs: bactericidal action, best man spectrum corresponds to Bleeding Time group, in addition Tetracycline the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides.